文献速递临床试验与 GCP流行病学与生物统计

智能手机应用帮助2型糖尿病患者管理血糖的疗效:析因设计试验方案

Efficacy of a smartphone application for helping individuals with type 2 diabetes mellitus manage their blood glucose: a protocol for factorial design trial.
PubMed 文献 · Trials · 2023-07-22

这是一项在中国成都两家三级医院内分泌门诊开展的2中心、析因设计、等比例分配、优效性试验,纳入至少18岁、糖化血红蛋白至少7.0%的2型糖尿病患者,随机分为常规护理组、常规护理加每周电话提醒组、常规护理加智能手机应用组、常规护理加应用加电话提醒组,干预6个月后分析糖化血红蛋白等结局。

要点

  • 2中心析因设计优效性试验,纳入糖化血红蛋白至少7.0%的2型糖尿病患者。
  • 四组分别为常规护理、加电话提醒、加智能手机应用、加应用加提醒。
  • 主要结局为6个月时糖化血红蛋白,次要结局包括血糖监测频率等。

核心结论

  • 该试验将确定智能手机应用能否改善中国2型糖尿病患者的血糖管理。
  • 研究结果可能有助于指导中国及其他地区开发有效的应用。

研究设计与样本

  • 2中心、析因设计、等比例分配、优效性试验,在中国成都两家三级医院内分泌门诊开展。
  • 纳入至少18岁、基于糖化血红蛋白至少7.0%诊断为2型糖尿病且会使用智能手机的个体。
  • 随机分为四组:常规护理加标准2型糖尿病及血糖控制教育(对照组)、常规护理加每周电话提醒自我监测血糖(提醒组)、常规护理加提供血糖控制和健康管理信息的智能手机应用(应用组)、常规护理加智能手机应用加每周电话提醒(应用加提醒组)。
  • 干预6个月后分析主要结局糖化血红蛋白及次要结局。

关键数值与推荐

  • 主要结局为6个月时的糖化血红蛋白。
  • 次要结局包括血糖监测频率、体重指数、血压、糖尿病知识、糖尿病相关健康信念、糖尿病自我管理行为及对智能手机应用的满意度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: China has the largest number of individuals with type 2 diabetes mellitus (T2DM) in the world, and most lack knowledge about glycemic control and health management. This trial will examine whether a smartphone application can improve blood glucose management among individuals with T2DM. METHODS: This will be a 2-center, factorial design, equal proportional distribution, superiority trial conducted in outpatient endocrinology clinics at two tertiary hospitals in Chengdu, China. The trial will enroll smartphone-literature individuals at least 18 years old who have been diagnosed with T2DM based on glycosylated hemoglobin (HbA1c) of at least 7.0%. Individuals will be randomly assigned to receive routine care with standard education about T2DM and glycemic control (Control), routine care as well as weekly telephone reminders to self-monitor blood glucose (Reminder), routine care and a smartphone application providing information about glycemic control and health management with T2DM (App), or the combination of routine care, the smartphone application, and weekly telephone reminders (App + Reminder). After 6 months of these interventions, participants will be analyzed for the primary outcome of HbA1c as well as the secondary outcomes of blood glucose monitoring frequency, body mass index, blood pressure, knowledge about diabetes, health beliefs related to diabetes, diabetes self-management behavior, and satisfaction with the smartphone application. DISCUSSION: This trial will determine whether a smartphone application can improve glycemic management among Chinese with T2DM. The findings may help guide the development of effective applications in China and elsewhere. TRIAL REGISTRATION: Registration in the Chinese Clinical Trial Registry (ChiCTR) under registration number ChiCTR2100042297: https://www.chictr.org.cn/bin/userProject . 17 January 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Tang H, Qin H, Zhang M, et al. Efficacy of a smartphone application for helping individuals with type 2 diabetes mellitus manage their blood glucose: a protocol for factorial design trial. Trials. 2023. PMID: 37480092. doi:10.1186/s13063-023-07489-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。